CoChat

Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Open access

The DOI matches its Crossref record; 135 of the 136 references it cites were found in a registry or an index.

Abstract

The convergence of advances in medical science, human biology, data science, and technology has enabled the generation of new insights into the phenotype known as "diabetes." Increased knowledge of this condition has emerged from populations around the world, illuminating the differences in how diabetes presents, its variable prevalence, and how best practice in treatment varies between populations. In parallel, focus has been placed on the development of tools for the application of precision medicine to numerous conditions. This Consensus Report presents the American Diabetes Association (ADA) Precision Medicine in Diabetes Initiative in partnership with the European Association for the Study of Diabetes (EASD), including its mission, the current state of the field, and prospects for the future. Expert opinions are presented on areas of precision diagnostics and precision therapeutics (including prevention and treatment), and key barriers to and opportunities for implementation of precision diabetes medicine, with better care and outcomes around the globe, are highlighted. Cases where precision diagnosis is already feasible and effective (i.e., monogenic forms of diabetes) are presented, while the major hurdles to the global implementation of precision diagnosis of complex forms of diabetes are discussed. The situation is similar for precision therapeutics, in which the appropriate therapy will often change over time owing to the manner in which diabetes evolves within individual patients. This Consensus Report describes a foundation for precision diabetes medicine, while highlighting what remains to be done to realize its potential. This, combined with a subsequent, detailed evidence-based review (due 2022), will provide a roadmap for precision medicine in diabetes that helps improve the quality of life for all those with diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dci20-0022

Cites

135 of 136 references verified0 citation errors · 1 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 136 references

Research works printed but not linked: 1

  1. Rewers M, Stene LC, Norris JM Chapter 11: Risk factors for type 1 diabetes. In Diabetes in America, 3rd ed Cowie CC, Casagrande SS, Menke A,, Eds. Bethesda, MD, National Institutes of Health, 2018

Cited by

Metadata

Authors
Chung, W. K., Erion, K., Florez, J. C., Hattersley, A. T., Hivert, M.-F., Lee, C. G., McCarthy, M. I., Nolan, J. J., Norris, J. M., Pearson, E. R., Philipson, L., McElvaine, A. T., Cefalu, W. T., Rich, S. S., & Franks, P. W.
Affiliations
  • Columbia University Irving Medical Center (US)
  • American Diabetes Association (US)
  • Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA
  • University of Exeter (GB)
  • Harvard University (US)
  • National Institute of Diabetes and Digestive and Kidney Diseases (US)
  • Centre for Human Genetics (GB)
  • Trinity College Dublin (IE)
  • Colorado School of Public Health (US)
  • University of Dundee (GB)
  • University of Chicago (US)
  • Duke University (US)
  • University of Virginia (US)
Corresponding author
Franks, Paul W.
Venue
Diabetes Care
Published
2020-06-11
Volume
43
Issue
7
Pages
1617-1635
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W3036199105
Cited by
400
References
136
Citations by year
2026: 50 · 2025: 57 · 2024: 74 · 2023: 92 · 2022: 72 · 2021: 47 · 2020: 8
FWCI
41.29
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion, other-oa)
  • Lund University Publications (Lund University) (submittedVersion)
  • Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion, public-domain)
Funders
  • American Diabetes Association (1-15-ACE-26)
  • Eli Lilly and Company
  • Pfizer
  • AstraZeneca
  • Sanofi
  • Regeneron Pharmaceuticals
  • Wellcome Trust (212259, 098381, 098395, 098395/Z/12/Z, 203141, 102820/Z/13/Z)
  • National Institute for Health and Care Research (NF-SI-0611-10219, NF-SI-0617-10090)
  • European Commission (115317, 115881, 875534, 098381)
  • Lunds Universitet
  • Novo Nordisk
  • Vetenskapsrådet
  • Universitetet i Bergen
  • Servier
  • National Institutes of Health (5r21ai142483-02, DK26687, UL1TR001873)
  • Genentech
  • Medical Research Council (MR/K005707/1, MR/T032014/1)
  • National Institute of Allergy and Infectious Diseases (R21-AI142483)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-26687, R01DK104942, 212259, R01DK052431, R01DK122586, U01DK105535, DP3DK111906, DK 26687, DK104351, R01DK104351, DK122586, 098381, 203141, P30DK026687, U54DK118612, P30DK020595, DK-52431)
  • National Center for Advancing Translational Sciences
  • Janssen Pharmaceuticals
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD094150)
  • University of Colorado School of Medicine, Anschutz Medical Campus
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
precision medicine, diabetes mellitus, precision diagnostics, precision therapy, monogenic diabetes, diabetes prevention, diabetes treatment, implementation barriers, personalized medicine, diabetes phenotypes
MeSH terms
Diabetes Mellitus, Endocrinology, Europe, Financial Management, Health Plan Implementation, Humans, Practice Patterns, Physicians', Quality of Life, Societies, Medical, United States, Evidence-Based Medicine, Consensus, Biomedical Research, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.